KKR (NYSE: KKR), Lender Processing Services Incorporated (NYSE: LPS), Medtronic, Inc. (NYSE: MDT), CME Group Inc. (NYSE: CME), Wynn Resorts, Limited (NASDAQ: WYNN) and Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA) had price targets on them adjusted by analysts.
KKR (KKR) had its price target lowered by Barclays Capital (NYSE:BCS) from $20.00 to $18.00. They have an “Overweight” rating on the company.
Lender Processing Services Incorporated (LPS) had its price target lowered by Barclays Capital from $20.00 to $17.00. They have an “Equal Weight” rating on the company.
Medtronic, Inc. (MDT) had its price target raised by Barclays Capital from $38.00 to $41.00. They have an “Equal Weight” rating on the company.
CME Group Inc. (CME) had its price target lowered by Barclays Capital from $347.00 to $281.00. They have an “Equal Weight” rating on the company.
Wynn Resorts, Limited (WYNN) had its price target lowered by Deutsche Bank (NYSE:DB) to $157.00.
Ulta Salon, Cosmetics & Fragrance, Inc. (ULTA) had its price target raised by RBC Capital from $76.00 to $78.00. They have a “Sector Perform” rating on the company.
Showing posts with label Medtronic. Show all posts
Showing posts with label Medtronic. Show all posts
Monday, January 9, 2012
Friday, December 30, 2011
Medtronic (MDT) Ratings, Price Targets
Updates on Medtronic (NYSE: MDT) ratings and price targets.
Citigroup (NYSE: C) raised their price target on Medtronic (NYSE: MDT) to $44.00.
Susquehanna initiated coverage on Medtronic. They placed a “Neutral” rating and a price target of $40.00 on the company.
Standpoint Research downgraded Medtronic from a “Buy” rating to a “Hold” rating.
Medtronic closed Thursday at $38.34, climbing $0.91, or 2.43 percent. They have a market cap over $40 billion.
Citigroup (NYSE: C) raised their price target on Medtronic (NYSE: MDT) to $44.00.
Susquehanna initiated coverage on Medtronic. They placed a “Neutral” rating and a price target of $40.00 on the company.
Standpoint Research downgraded Medtronic from a “Buy” rating to a “Hold” rating.
Medtronic closed Thursday at $38.34, climbing $0.91, or 2.43 percent. They have a market cap over $40 billion.
Thursday, December 29, 2011
Medtronic (MDT) Ratings, Price Targets
Updates on Medtronic (NYSE: MDT) ratings and price targets.
Citigroup (NYSE: C) raised its price target on Medtronic (MDT) to $44.00 in a note today.
Other recent analysts' actions on Medtronic include Standpoint Research downgrading them from a "Buy" rating to a "Hold" rating.
Zacks Investment Research reiterated a “Neutral” rating on Medtronic. They have a price target of $35.00 on the firm.
Susquehanna initiated coverage on Medtronic. They have a "Neutral" rating and price target of $40.00 on the firm.
Citigroup (NYSE: C) raised its price target on Medtronic (MDT) to $44.00 in a note today.
Other recent analysts' actions on Medtronic include Standpoint Research downgrading them from a "Buy" rating to a "Hold" rating.
Zacks Investment Research reiterated a “Neutral” rating on Medtronic. They have a price target of $35.00 on the firm.
Susquehanna initiated coverage on Medtronic. They have a "Neutral" rating and price target of $40.00 on the firm.
Tuesday, December 20, 2011
ResMed (RMD) (CCI) (CELL) (MDT) (MS) (TKLC) Ratings, Price Targets
ResMed Inc. (NYSE: RMD), Crown Castle (NYSE: CCI), Brightpoint Inc. (NASDAQ: CELL), Medtronic, Inc. (NYSE: MDT), Morgan Stanley (NYSE: MS) and Tekelec (NASDAQ: TKLC) ratings and price targets.
Zacks Investment Research reiterated its "Neutral" rating on Crown Castle (CCI). They have a price target of $45.00 on the company.
Canaccord Genuity reiterated its "Buy" rating on Brightpoint Inc. (CELL).
Susquehanna initiated coverage on Medtronic, Inc. (MDT). They have a “Neutral” rating and a price target of $40.00 on the company.
Evercore Partners initiated coverage on Morgan Stanley (MS). They have an “Equal Weight” rating on the company.
Tekelec (TKLC) was downgraded by Sidoti from a “Buy” rating to a “Neutral” rating.
ResMed Inc. (RMD) was upgraded by Feltl & Co from a “Buy” rating to a “Strong Buy” rating. They have a price target of $35.00 on the company.
Zacks Investment Research reiterated its "Neutral" rating on Crown Castle (CCI). They have a price target of $45.00 on the company.
Canaccord Genuity reiterated its "Buy" rating on Brightpoint Inc. (CELL).
Susquehanna initiated coverage on Medtronic, Inc. (MDT). They have a “Neutral” rating and a price target of $40.00 on the company.
Evercore Partners initiated coverage on Morgan Stanley (MS). They have an “Equal Weight” rating on the company.
Tekelec (TKLC) was downgraded by Sidoti from a “Buy” rating to a “Neutral” rating.
ResMed Inc. (RMD) was upgraded by Feltl & Co from a “Buy” rating to a “Strong Buy” rating. They have a price target of $35.00 on the company.
Wednesday, November 23, 2011
Medtronic (MDT) Ratings Reiterated
Medtronic, Inc. (NYSE: MDT) had ratings on them reiterated by analysts.
Collins Stewart reiterated its "Neutral" rating on Medtronic, Inc. (MDT). They have a price target of $37.00 on the company.
Goldman Sachs (NYSE:GS) reiterated its "Neutral" rating on Medtronic, Inc.
Deutsche Bank (NYSE:DB) reiterated its "Buy" rating on Medtronic, Inc. They have a price target of $43.00 on the company.
JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Neutral" rating on Medtronic, Inc.
Collins Stewart reiterated its "Neutral" rating on Medtronic, Inc. (MDT). They have a price target of $37.00 on the company.
Goldman Sachs (NYSE:GS) reiterated its "Neutral" rating on Medtronic, Inc.
Deutsche Bank (NYSE:DB) reiterated its "Buy" rating on Medtronic, Inc. They have a price target of $43.00 on the company.
JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Neutral" rating on Medtronic, Inc.
Monday, November 21, 2011
Medtronic (MDT) (UNP) (MELA) (MHR) (MS) (MWV) Ratings, Price Targets
Medtronic, Inc. (MDT), Union Pacific (UNP), MELA Sciences Inc. (MELA), Magnum Hunter (MHR), Morgan Stanley (MS) and MeadWestvaco Corp. (MWV) ratings and price targets.
Morgan Stanley (NYSE:MS) reiterated its “Overweight” rating on Union Pacific (UNP).
Citigroup (NYSE:C) reiterated its “Buy” rating on Medtronic, Inc. (MDT). They have a price target of $40.00 on the company.
Needham & Company reiterated its “Buy” rating on MELA Sciences Inc. (MELA).
Jefferies (NYSE:JEF) reiterated its “Buy” rating on Magnum Hunter (MHR). They have a price target of $9.00 on the company.
Collins Stewart upgraded Morgan Stanley (MS) from a “Hold” rating to a “Buy” rating. They have a price target of $21.00 on the company.
BMO Capital Markets upgraded MeadWestvaco Corp. (MWV) from an “Underperform” rating to a “Market Perform” rating. They have a price target of $33.00 on the company, up from $27.50.
Morgan Stanley (NYSE:MS) reiterated its “Overweight” rating on Union Pacific (UNP).
Citigroup (NYSE:C) reiterated its “Buy” rating on Medtronic, Inc. (MDT). They have a price target of $40.00 on the company.
Needham & Company reiterated its “Buy” rating on MELA Sciences Inc. (MELA).
Jefferies (NYSE:JEF) reiterated its “Buy” rating on Magnum Hunter (MHR). They have a price target of $9.00 on the company.
Collins Stewart upgraded Morgan Stanley (MS) from a “Hold” rating to a “Buy” rating. They have a price target of $21.00 on the company.
BMO Capital Markets upgraded MeadWestvaco Corp. (MWV) from an “Underperform” rating to a “Market Perform” rating. They have a price target of $33.00 on the company, up from $27.50.
Thursday, November 17, 2011
Micron (MU) (MDT) (MPC) (TGT) (MRVL) (TFM) Ratings, Price Targets
Micron Technology, Inc. (MU), Medtronic, Inc. (MDT), Marathon Petroleum (MPC), Target Corp. (TGT), Marvell Technology Group (MRVL) and The Fresh Market Inc. (TFM) ratings and price targets.
Morgan Stanley (NYSE:MS) reiterated its “Equal Weight” rating on Medtronic, Inc. (MDT).
Morgan Stanley reiterated its “Overweight” rating on shares of Marathon Petroleum (MPC).
Piper Jaffray (NYSE:PJC) downgraded The Fresh Market Inc (TFM) from an “Overweight” rating to a “Neutral” rating. They have a price target of $45.00 on the company.
Piper Jaffray raised its price target on Target Corp. (TGT) to $63.00.
JMP Securities downgraded Marvell Technology Group (MRVL) from a “Market Perform” rating to an “Underperform” rating.
Oppenheimer upgraded Micron Technology, Inc. (MU) from a “Perform” rating to an “Outperform” rating. They have a price target of $8.00 on the company.
Morgan Stanley (NYSE:MS) reiterated its “Equal Weight” rating on Medtronic, Inc. (MDT).
Morgan Stanley reiterated its “Overweight” rating on shares of Marathon Petroleum (MPC).
Piper Jaffray (NYSE:PJC) downgraded The Fresh Market Inc (TFM) from an “Overweight” rating to a “Neutral” rating. They have a price target of $45.00 on the company.
Piper Jaffray raised its price target on Target Corp. (TGT) to $63.00.
JMP Securities downgraded Marvell Technology Group (MRVL) from a “Market Perform” rating to an “Underperform” rating.
Oppenheimer upgraded Micron Technology, Inc. (MU) from a “Perform” rating to an “Outperform” rating. They have a price target of $8.00 on the company.
Thursday, August 25, 2011
Brown Shoe (BWS) (JWN) (MDT) (SFL) (SWY) Declare Dividends
The Board of Directors of Brown Shoe Company Inc. (NYSE:BWS) declared a quarterly common stock dividend of $0.07 per share payable 10/3/11 to shareholders of record at the close of business on 9/16/11.
The Board of Directors of Nordstrom Inc. (NYSE:JWN) declared a quarterly common stock dividend of $0.23 per share payable 9/15/11 to shareholders of record at the close of business on 9/6/11.
The Board of Directors of Medtronic Inc. (NYSE:MDT) declared a second quarter common stock dividend of $0.2425 per share payable 10/28/11 to shareholders of record at the close of business on 10/7/11.
The Board of Directors of Ship Finance International (NYSE:SFL) declared a quarterly common stock dividend of $0.39 per share payable 9/29/11 to shareholders of record at the close of business on 9/9/11.
The Board of Directors of Safeway Inc. (NYSE:SWY) declared a quarterly common stock dividend of $0.145 per share payable 10/13/11 to shareholders of record at the close of business on 9/22/11.
The Board of Directors of Nordstrom Inc. (NYSE:JWN) declared a quarterly common stock dividend of $0.23 per share payable 9/15/11 to shareholders of record at the close of business on 9/6/11.
The Board of Directors of Medtronic Inc. (NYSE:MDT) declared a second quarter common stock dividend of $0.2425 per share payable 10/28/11 to shareholders of record at the close of business on 10/7/11.
The Board of Directors of Ship Finance International (NYSE:SFL) declared a quarterly common stock dividend of $0.39 per share payable 9/29/11 to shareholders of record at the close of business on 9/9/11.
The Board of Directors of Safeway Inc. (NYSE:SWY) declared a quarterly common stock dividend of $0.145 per share payable 10/13/11 to shareholders of record at the close of business on 9/22/11.
Trina Solar (TSL) (CCMP) (TIN) (COCO) (MDT) (DXCM) Price Targets Changed
Trina Solar (NYSE: TSL), Cabot Microelectronics Co. (NASDAQ: CCMP), Temple-Inland (NYSE: TIN), Corinthian Colleges, Inc. (NASDAQ: COCO), Medtronic, Inc. (NYSE: MDT) and DexCom Inc (NASDAQ: DXCM) had their price targets adjusted by analysts.
Trina Solar (TSL) had its price target lowered by Ardour Capital from $30.00 to $24.00. They have a “Buy” rating on the company.
Cabot Microelectronics Co. (CCMP) had its price target lowered by Ticonderoga from $68.00 to $57.00. They have a “Buy” rating on the company.
Temple-Inland (TIN) had its price target lowered by Longbow Research from $35.00 to $27.00. They have a “Buy” rating on the company.
Corinthian Colleges, Inc. (COCO) had its price target lowered by FBR Capital from $4.00 to $1.75. They have an “Underperform” rating on the company.
Medtronic, Inc. (MDT) had its price target lowered by Morgan Keegan from $43.00 to $38.00. They have a “Market Perform” rating on the company.
DexCom Inc. (DXCM) had its price target lowered by Morgan Keegan from $18.00 to $15.00. They have an “Outperform” rating on the company.
Trina Solar (TSL) had its price target lowered by Ardour Capital from $30.00 to $24.00. They have a “Buy” rating on the company.
Cabot Microelectronics Co. (CCMP) had its price target lowered by Ticonderoga from $68.00 to $57.00. They have a “Buy” rating on the company.
Temple-Inland (TIN) had its price target lowered by Longbow Research from $35.00 to $27.00. They have a “Buy” rating on the company.
Corinthian Colleges, Inc. (COCO) had its price target lowered by FBR Capital from $4.00 to $1.75. They have an “Underperform” rating on the company.
Medtronic, Inc. (MDT) had its price target lowered by Morgan Keegan from $43.00 to $38.00. They have a “Market Perform” rating on the company.
DexCom Inc. (DXCM) had its price target lowered by Morgan Keegan from $18.00 to $15.00. They have an “Outperform” rating on the company.
Tuesday, August 16, 2011
JinkoSolar (JKS) (DELL) (NTAP) (DV) (GXP) (MDT) (NRG) Price Targets Changed
JinkoSolar Holding Co., Ltd. (NYSE: JKS), Dell Inc. (NASDAQ: DELL), NetApp Inc. (NASDAQ: NTAP), DeVry Inc. (NYSE: DV), Great Plains Energy (NYSE: GXP), Medtronic, Inc. (NYSE: MDT) and NRG Energy, Inc. (NYSE: NRG) price targets adjusted by analysts.
JinkoSolar Holding Co., Ltd. (JKS) had its price target lowered
by Collins Stewart from $28.00 to $24.00. They have a “Buy” rating on the company.
Dell Inc. (DELL) had its price target raised by UBS AG (NYSE:UBS) to $19.00. They have a “Buy” rating on the company.
NetApp Inc. (NTAP) had its price target lowered by RBC Capital from $71.00 to $61.00. They have an “Outperform” rating on the company.
DeVry Inc. (DV) had its price target lowered by Citigroup (NYSE:C) to $64.00. They have a “Buy” rating on the company. They cited valuation as the catalyst behind the call.
Great Plains Energy (GXP) had its price target lowered by Wunderlich from $21.00 to $20.00. They have a "Buy” rating on the company.
Medtronic, Inc. (MDT) had its price target lowered by Citigroup to $40.00. They have a “Buy” rating on the company.
NRG Energy, Inc. (NRG) had its price target raised by Goldman Sachs (NYSE:GS) to $26.00. They have a “Neutral” rating on the company.
JinkoSolar Holding Co., Ltd. (JKS) had its price target lowered
by Collins Stewart from $28.00 to $24.00. They have a “Buy” rating on the company.
Dell Inc. (DELL) had its price target raised by UBS AG (NYSE:UBS) to $19.00. They have a “Buy” rating on the company.
NetApp Inc. (NTAP) had its price target lowered by RBC Capital from $71.00 to $61.00. They have an “Outperform” rating on the company.
DeVry Inc. (DV) had its price target lowered by Citigroup (NYSE:C) to $64.00. They have a “Buy” rating on the company. They cited valuation as the catalyst behind the call.
Great Plains Energy (GXP) had its price target lowered by Wunderlich from $21.00 to $20.00. They have a "Buy” rating on the company.
Medtronic, Inc. (MDT) had its price target lowered by Citigroup to $40.00. They have a “Buy” rating on the company.
NRG Energy, Inc. (NRG) had its price target raised by Goldman Sachs (NYSE:GS) to $26.00. They have a “Neutral” rating on the company.
Apple (AAPL) (MDT) (BLK) (BOPH) (GOOG) (ITW) (MASI) Get New Coverage
Apple, Inc (NASDAQ: AAPL), Medtronic, Inc. (NYSE: MDT), BlackRock, Inc. (NYSE: BLK), Bohai Pharmaceuticals Group, Inc. (OTC: BOPH), Google Inc. (NASDAQ: GOOG), Illinois Tool Works Inc. (NYSE: ITW) and Masimo Corp (NASDAQ: MASI) getting new analyst coverage.
Hilliard Lyons initiated coverage on Apple, Inc. (AAPL). They placed a “Buy” rating and a price target of $475.00 on the company.
Standpoint Research initiated coverage on Medtronic, Inc. (MDT). They placed an “Accumulate” rating and a price target of $38.00 on the company.
Standpoint Research initiated coverage on BlackRock, Inc. (BLK). They placed an “Accumulate” rating and a price target of $195.00 on the company.
Feltl & Co. initiated coverage on Masimo Corporation (MASI). They placed a “Hold” rating on the company.
Dawson James initiated coverage on Bohai Pharmaceuticals Group, Inc. (BOPH). They placed a “Buy” rating and a price target of $3.00 on the company.
Hilliard Lyons initiated coverage on Google Inc. (GOOG). They placed a “Buy” rating and a price target of $700.00 on the company.
Standpoint Research initiated coverage on Illinois Tool Works Inc. (ITW). They placed an “Accumulate” rating and a price target of $55.00 on the company.
Hilliard Lyons initiated coverage on Apple, Inc. (AAPL). They placed a “Buy” rating and a price target of $475.00 on the company.
Standpoint Research initiated coverage on Medtronic, Inc. (MDT). They placed an “Accumulate” rating and a price target of $38.00 on the company.
Standpoint Research initiated coverage on BlackRock, Inc. (BLK). They placed an “Accumulate” rating and a price target of $195.00 on the company.
Feltl & Co. initiated coverage on Masimo Corporation (MASI). They placed a “Hold” rating on the company.
Dawson James initiated coverage on Bohai Pharmaceuticals Group, Inc. (BOPH). They placed a “Buy” rating and a price target of $3.00 on the company.
Hilliard Lyons initiated coverage on Google Inc. (GOOG). They placed a “Buy” rating and a price target of $700.00 on the company.
Standpoint Research initiated coverage on Illinois Tool Works Inc. (ITW). They placed an “Accumulate” rating and a price target of $55.00 on the company.
Wednesday, August 10, 2011
EnerNOC (ENOC) (ZMH) (AHONY) (BCR) (MDT) (OSK) Downgraded
EnerNOC, Inc. (NASDAQ: ENOC), Zimmer Holdings, Inc. (NYSE: ZMH), Koninklijke Ahold (NASDAQ: AHONY), C.R. Bard, Inc. (NYSE: BCR), Medtronic, Inc. (NYSE: MDT) and Oshkosh Truck (NYSE: OSK) downgraded by analysts.
EnerNOC, Inc. (ENOC) was downgraded by Ardour Capital from an “Accumulate” rating to a “Hold” rating. They have a price target of $14.00 on the company, down from $24.00.
Zimmer Holdings, Inc. (ZMH) was downgraded by Goldman Sachs (NYSE:GS) from a “Neutral” rating to a “Sell” rating.
Koninklijke Ahold (AHONY) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) from a “Neutral” rating to a “Hold” rating.
C.R. Bard, Inc. (BCR) was downgraded by Goldman Sachs from a “Neutral” rating to a “Sell” rating.
Medtronic, Inc. (MDT) was downgraded by Goldman Sachs from a “Buy” rating to a “Neutral” rating.
Oshkosh Truck (OSK) was downgraded by Goldman Sachs from a “Neutral” rating to a “Sell” rating.
EnerNOC, Inc. (ENOC) was downgraded by Ardour Capital from an “Accumulate” rating to a “Hold” rating. They have a price target of $14.00 on the company, down from $24.00.
Zimmer Holdings, Inc. (ZMH) was downgraded by Goldman Sachs (NYSE:GS) from a “Neutral” rating to a “Sell” rating.
Koninklijke Ahold (AHONY) was downgraded by JPMorgan Chase & Co. (NYSE:JPM) from a “Neutral” rating to a “Hold” rating.
C.R. Bard, Inc. (BCR) was downgraded by Goldman Sachs from a “Neutral” rating to a “Sell” rating.
Medtronic, Inc. (MDT) was downgraded by Goldman Sachs from a “Buy” rating to a “Neutral” rating.
Oshkosh Truck (OSK) was downgraded by Goldman Sachs from a “Neutral” rating to a “Sell” rating.
Monday, May 9, 2011
Price Targets on (WCG) (WR) (WTR) (MHK) (MDT) Updated
Analysts updated their price targets on WellCare Group (NYSE: WCG), Westar Energy, Inc. (NYSE: WR), Aqua America (NYSE: WTR), Mohawk Industries, Inc. (NYSE: MHK) and Medtronic, Inc. (NYSE: MDT) today.
Goldman Sachs (NYSE:GS) raised their price target on WellCare Group (WCG) to $57.00. They have a “buy” rating on the company.
Bank of America (NYSE:BAC) raised their price target on Westar Energy, Inc. (WR) from $27.00 to $29.00. They have a “buy” rating on the company.
Brean Murray raised their price target on Aqua America (WTR) from $26.00 to $29.00. They have a “buy” rating on the company.
Citigroup (NYSE:C) raised their price target on Mohawk Industries, Inc. (MHK) from $66.00 to $68.00.
Oppenheimer raised their price target on Medtronic, Inc. (MDT) from $42.00 to $48.00. They have an “outperform” rating on the company.
Goldman Sachs (NYSE:GS) raised their price target on WellCare Group (WCG) to $57.00. They have a “buy” rating on the company.
Bank of America (NYSE:BAC) raised their price target on Westar Energy, Inc. (WR) from $27.00 to $29.00. They have a “buy” rating on the company.
Brean Murray raised their price target on Aqua America (WTR) from $26.00 to $29.00. They have a “buy” rating on the company.
Citigroup (NYSE:C) raised their price target on Mohawk Industries, Inc. (MHK) from $66.00 to $68.00.
Oppenheimer raised their price target on Medtronic, Inc. (MDT) from $42.00 to $48.00. They have an “outperform” rating on the company.
Monday, May 2, 2011
Dividend Yields for (BAX) (MDT) (BDX) (CAH) (STJ)
Indicated dividend yields for Standard & Poor's 500 Index companies Baxter International Inc (BAX), Medtronic Inc (MDT), Becton Dickinson and Co (BDX), Cardinal Health Inc (CAH) and St Jude Medical Inc. (STJ).
These dividend data indicate dividend yields of companies in the Standard & Poor's 500 Index as of Saturday, April 30. The yield is determined by taking the latest declared dividend, annualized and divided by the price of the stock. Payout ratios are calculated based on latest quarterly dividend paid divided by earnings.
Baxter International Inc (BAX) has a dividend yield of 2.18 percent on a declared dividend of $0.31. The payout ratio is 31.4 percent.
Medtronic Inc (MDT) has a dividend yield of 2.16 percent on a declared dividend of $0.23. The payout ratio is 26.2 percent.
Becton Dickinson and Co (BDX) has a dividend yield of 1.91 percent on a declared dividend of $0.41. The payout ratio is 29.1 percent.
Cardinal Health Inc (CAH) has a dividend yield of 1.78 percent on a declared dividend of $0.20. The payout ratio is 27.2 percent.
St Jude Medical Inc (STJ) has a dividend yield of 1.57 percent on a declared dividend of $0.21. The payout ratio is na.
These dividend data indicate dividend yields of companies in the Standard & Poor's 500 Index as of Saturday, April 30. The yield is determined by taking the latest declared dividend, annualized and divided by the price of the stock. Payout ratios are calculated based on latest quarterly dividend paid divided by earnings.
Baxter International Inc (BAX) has a dividend yield of 2.18 percent on a declared dividend of $0.31. The payout ratio is 31.4 percent.
Medtronic Inc (MDT) has a dividend yield of 2.16 percent on a declared dividend of $0.23. The payout ratio is 26.2 percent.
Becton Dickinson and Co (BDX) has a dividend yield of 1.91 percent on a declared dividend of $0.41. The payout ratio is 29.1 percent.
Cardinal Health Inc (CAH) has a dividend yield of 1.78 percent on a declared dividend of $0.20. The payout ratio is 27.2 percent.
St Jude Medical Inc (STJ) has a dividend yield of 1.57 percent on a declared dividend of $0.21. The payout ratio is na.
Wednesday, April 20, 2011
St. Jude Medical (STJ) Earnings Drop Ends Streak
Shares of St. Jude Medical (NYSE:STJ) are trading strong even after a disappointing quarter where net income for St. Jude Medical, Inc. was down to $233.4 million, or 71 cents a share, vs. $238.6 million, or 73 cents a share last year in the same quarter, a decline of 2.2 percent.
Revenue jumped for the quarter, rising 9 percent to $1.38 billion.
St. Jude Medical missed on the average analyst estimate of 78 cents a share. Estimates ranged from 77 cents a share to 80 cents a share.
St. Jude Medical Chairman, President and Chief Executive Officer Daniel J. Starks said, “During the first quarter, we continued to make good progress in developing the new growth drivers we need to return to double-digit sales growth on a sustainable basis. Our gross margin has strengthened, we have continued to invest in research and development at an elevated rate, and our sales and earnings growth outlook have both improved. We are off to a good start making 2011 another very successful year for St. Jude Medical.”
Major competitors of St. Jude Medical include Medtronic, Inc. (NYSE:MDT), Boston Scientific Corporation (NYSE:BSX), Intuitive Surgical, Inc. (NASDAQ:ISRG), Johnson & Johnson (NYSE:JNJ), and Edwards Lifesciences Corp. (NYSE:EW).
St. Jude Medical was trading at $52.75, gaining $1.75, or 3.43 percent, as of 1:22 PM EDT.
Revenue jumped for the quarter, rising 9 percent to $1.38 billion.
St. Jude Medical missed on the average analyst estimate of 78 cents a share. Estimates ranged from 77 cents a share to 80 cents a share.
St. Jude Medical Chairman, President and Chief Executive Officer Daniel J. Starks said, “During the first quarter, we continued to make good progress in developing the new growth drivers we need to return to double-digit sales growth on a sustainable basis. Our gross margin has strengthened, we have continued to invest in research and development at an elevated rate, and our sales and earnings growth outlook have both improved. We are off to a good start making 2011 another very successful year for St. Jude Medical.”
Major competitors of St. Jude Medical include Medtronic, Inc. (NYSE:MDT), Boston Scientific Corporation (NYSE:BSX), Intuitive Surgical, Inc. (NASDAQ:ISRG), Johnson & Johnson (NYSE:JNJ), and Edwards Lifesciences Corp. (NYSE:EW).
St. Jude Medical was trading at $52.75, gaining $1.75, or 3.43 percent, as of 1:22 PM EDT.
Wednesday, March 16, 2011
Medical Device Makers (VOLC) (EW) (XRAY) Among Hardest Hit in Japan
A large number of sectors have been hit hard in Japan, depending on the exposure they have to the country, and one not mentioned too much so far is the medical devices market, where those with the most exposure to Japan are Volcano Corp (NASDAQ:VOLC) Edwards Lifesciences Corp (NYSE:EW) and Dentsply International Inc (NASDAQ:XRAY).
About 30 percent of revenue generated by Volcano comes from Japan. Dentsply said key suppliers have been disrupted and has withdrawn its earnings guidance for 2011. Edwards Lifesciences Corp., which makes heart valves, generates about 17 percent of its revenue in Japan. At worst, Edwards sees disruptions being temporary and see no materially impact financial results from the earthquake damage.
Even so, analysts say every company should experience some degree of loss of sales as a result of the natural disaster.
Others device makers with significant exposure in Japan are Boston Scientific Corp (NYSE:BSX), with 12 percent of total sales in Japan, St Jude Medical Inc (NYSE:STJ) and Wright Medical Group Inc (NASDAQ:WMGI) at 11 percent each, Stryker Corp (NYSE:SYK) at 10 percent and Zimmer Holdings Inc (NYSE:ZMH) at 9 percent.
Larger diversified firms with less exposure are Medtronic Inc (NYSE:MDT), Johnson & Johnson (NYSE:JNJ) and Abbott Laboratories (NYSE:ABT) with from 5 percent to 6 percent of sales coming from Japan.
Of drugmakers, the largest exposure is Merck & Co Inc (NYSE:MRK) with about 8 percent of sales coming from Japan. Bristol Myers Squibb (NYSE:BMY) only has about 3 percent of sales come from there.
Volcano Corp. closed Tuesday at $23.56, down $1.21, or 4.88 percent. Edwards Lifesciences closed at $86.23, dropping $2.23, or 2.52 percent. Densply closed at $35.63, falling $1.55, or 4.17 percent.
About 30 percent of revenue generated by Volcano comes from Japan. Dentsply said key suppliers have been disrupted and has withdrawn its earnings guidance for 2011. Edwards Lifesciences Corp., which makes heart valves, generates about 17 percent of its revenue in Japan. At worst, Edwards sees disruptions being temporary and see no materially impact financial results from the earthquake damage.
Even so, analysts say every company should experience some degree of loss of sales as a result of the natural disaster.
Others device makers with significant exposure in Japan are Boston Scientific Corp (NYSE:BSX), with 12 percent of total sales in Japan, St Jude Medical Inc (NYSE:STJ) and Wright Medical Group Inc (NASDAQ:WMGI) at 11 percent each, Stryker Corp (NYSE:SYK) at 10 percent and Zimmer Holdings Inc (NYSE:ZMH) at 9 percent.
Larger diversified firms with less exposure are Medtronic Inc (NYSE:MDT), Johnson & Johnson (NYSE:JNJ) and Abbott Laboratories (NYSE:ABT) with from 5 percent to 6 percent of sales coming from Japan.
Of drugmakers, the largest exposure is Merck & Co Inc (NYSE:MRK) with about 8 percent of sales coming from Japan. Bristol Myers Squibb (NYSE:BMY) only has about 3 percent of sales come from there.
Volcano Corp. closed Tuesday at $23.56, down $1.21, or 4.88 percent. Edwards Lifesciences closed at $86.23, dropping $2.23, or 2.52 percent. Densply closed at $35.63, falling $1.55, or 4.17 percent.
Wells Fargo (WFC), Medtronic (MDT), General Mills (GIS) Latest to Offer Aid to Japan
As needs of Japan pile up, a growing number of corporations, including Wells Fargo (NYSE:WFC), Medtronic (NYSE:MDT) and General Mills (NYSE:GIS), are pledging dollars for aid.
Wells Fargo announced it would contribute as much as $1 million, with $500,000 going immediately to the American Red Cross to support the Japan Earthquake and Pacific Tsunami Fund. The bank added it would also match contributions from employees dollar for dollar, up to another $500,000.
General Mills said it pledged $650,000 to the Red Cross International Disaster Response Fund, while committing to match employee and retiree gifts to the Red Cross up to an additional $100,000.
Medtronic said it has committed $1 million in direct grants, employee matching grants and product donations. The company said the direct grants would go to organizations aiding relief efforts.
General Mills closed Tuesday at $36.55, down $0.37, or 1.00 percent. Medtronic closed at $37.31, falling $0.52, or 1.37 percent. Wells Fargo closed at $32.27, gaining $0.17, or 0.53 percent.
Wells Fargo announced it would contribute as much as $1 million, with $500,000 going immediately to the American Red Cross to support the Japan Earthquake and Pacific Tsunami Fund. The bank added it would also match contributions from employees dollar for dollar, up to another $500,000.
General Mills said it pledged $650,000 to the Red Cross International Disaster Response Fund, while committing to match employee and retiree gifts to the Red Cross up to an additional $100,000.
Medtronic said it has committed $1 million in direct grants, employee matching grants and product donations. The company said the direct grants would go to organizations aiding relief efforts.
General Mills closed Tuesday at $36.55, down $0.37, or 1.00 percent. Medtronic closed at $37.31, falling $0.52, or 1.37 percent. Wells Fargo closed at $32.27, gaining $0.17, or 0.53 percent.
Tuesday, February 15, 2011
Paulson Adds Transocean (NYSE:RIG), Anadarko (NYSE:APC), Keeps Core Holdings
As a number of hedge funds and managers of holding companies are revealing their investments in the fourth quarter via 13-F filings with the SEC, a trend is emerging as far as funds and companies holding onto their core assets, while also venturing a little further into energy and financial stocks.
That's true with John Paulson and his fund as well, which kept his top long-term holdings in place, but added big in energy and healthcare.
For energy, he took big stakes in Anadarko Petroleum (NYSE:APC) and Transocean (NYSE:RIG); both connected to BP's (NYSE:BP) oil spill.
Paulson added 7.8 million shares of Anadarko and 7.2 million shares of Transocean to his portfolio. His fund now owns over 21 million shares of Anadarko.
In the health sector, he took new stakes in Medtronic Inc (NYSE:MDT), Teva Pharmaceutical (NASDAQ:TEVA) and Baxter International (NYSE:BAX).
He also boosted his stake in biotechnology firm Genzyme Corp (NASDAQ:GENZ) to 6.8 million shares, which is close to being taken over by France-based Sanofi-Aventis.
Core holdings he continues to hold onto are SPDR Gold Trust (NYSEArca:GLD), AngloGold Ashanti (NYSE:AU), Citigroup (NYSE:C) and Bank of America (NYSE:BAC).
In what appears to be based on Paulson's thoughts people are spending more, he dropped discount retailer (NYSE:FDO) from his holdings and added J. Crew (NYSE:JCG).
That's true with John Paulson and his fund as well, which kept his top long-term holdings in place, but added big in energy and healthcare.
For energy, he took big stakes in Anadarko Petroleum (NYSE:APC) and Transocean (NYSE:RIG); both connected to BP's (NYSE:BP) oil spill.
Paulson added 7.8 million shares of Anadarko and 7.2 million shares of Transocean to his portfolio. His fund now owns over 21 million shares of Anadarko.
In the health sector, he took new stakes in Medtronic Inc (NYSE:MDT), Teva Pharmaceutical (NASDAQ:TEVA) and Baxter International (NYSE:BAX).
He also boosted his stake in biotechnology firm Genzyme Corp (NASDAQ:GENZ) to 6.8 million shares, which is close to being taken over by France-based Sanofi-Aventis.
Core holdings he continues to hold onto are SPDR Gold Trust (NYSEArca:GLD), AngloGold Ashanti (NYSE:AU), Citigroup (NYSE:C) and Bank of America (NYSE:BAC).
In what appears to be based on Paulson's thoughts people are spending more, he dropped discount retailer (NYSE:FDO) from his holdings and added J. Crew (NYSE:JCG).
Tuesday, December 21, 2010
Medtronic (NYSE:MDT) CEO William Hawkins Stepping Down
After a relatively lackluster share performance after3 years at the helm of Medtronic (NYSE:MDT), Chief Executive Officer William A. Hawkins will be stepping down in April, and will stay on he said , until a successor is found.
Hawkins will retire in April, the end of the fiscal year of the medical device company. The company said they're looking externally for candidates at this time.
J.P. Morgan's (NYSE:JPM) Michael Weinstein said, “Medtronic has struggled to create shareholder value over the last 10 years, and given the challenges facing the company and industry, it’s not getting any easier. The good news is that a new CEO can be a catalyst for change, and in the cold winter of the Twin Cities, that starts today.”
The apparent reason for searching for an external candidate is to get a fresh perspective on the strategy of the company in a maturing industry.
If no one is found outside the company, internal possibilities are Michael Coyle or Christopher O'Connell, both executive vice presidents with Medtronic.
Hawkins will retire in April, the end of the fiscal year of the medical device company. The company said they're looking externally for candidates at this time.
J.P. Morgan's (NYSE:JPM) Michael Weinstein said, “Medtronic has struggled to create shareholder value over the last 10 years, and given the challenges facing the company and industry, it’s not getting any easier. The good news is that a new CEO can be a catalyst for change, and in the cold winter of the Twin Cities, that starts today.”
The apparent reason for searching for an external candidate is to get a fresh perspective on the strategy of the company in a maturing industry.
If no one is found outside the company, internal possibilities are Michael Coyle or Christopher O'Connell, both executive vice presidents with Medtronic.
Friday, December 10, 2010
Medtronic (NYSE:MDT) Generates Over 40 Percent of Revenue Outside US
Commenting on a recent filing by Medtronic, Inc. (NYSE:MDT), Barclays (NYSE:BCS) noted several disclosures of the company, including they've generated over 40 percent of their revenue outside the U.S., mostly in the Asia, Pacific region.
Barclays noted, "The filing contained a number of interesting disclosures: 1) In F2Q, we note that MDT generated - 41% of its revenue from outside the US, in-line with last quarter as weakness in Europe was offset by strength in Asia-Pac and other international regions; 2) MDT disclosed operating income data for its two operating segments, Cardiac/Vascular and Restorative Therapies noting operating margins of - 34% and - 28% respectively, each up - 200 bps over prior year levels. 3) MDT noted that - $2.5 billion of its $7 billion in LT debt is due within the next year but we note that MDT has a clean balance sheet with a Debt/TTM EBITDA of - 1.8x as of October 29, 2010; 4) MDT disclosed that, as of October 29, 2010 it had - $3.2 billion outstanding of unused credit lines with various banks; 5) MDT repurchased nearly - 3 million shares during F2Q and has - 32 million shares remaining under current buyback authorizations; 6) MDT provided detail on its recent acquisitions including Ardian, ATS Medical, and Invatec. 7) MDT noted that the future launch timing of certain devices within in Cardiac and Vascular group will be impacted by the timing of the final resolution to the company's Mounds View warning letter."
Barclays maintains an 'Overweight' on Medtronic, Inc., which closed Thursday at $35.21, up $0.50, or 1.44 percent. They have a price target of $38 on them.
Barclays noted, "The filing contained a number of interesting disclosures: 1) In F2Q, we note that MDT generated - 41% of its revenue from outside the US, in-line with last quarter as weakness in Europe was offset by strength in Asia-Pac and other international regions; 2) MDT disclosed operating income data for its two operating segments, Cardiac/Vascular and Restorative Therapies noting operating margins of - 34% and - 28% respectively, each up - 200 bps over prior year levels. 3) MDT noted that - $2.5 billion of its $7 billion in LT debt is due within the next year but we note that MDT has a clean balance sheet with a Debt/TTM EBITDA of - 1.8x as of October 29, 2010; 4) MDT disclosed that, as of October 29, 2010 it had - $3.2 billion outstanding of unused credit lines with various banks; 5) MDT repurchased nearly - 3 million shares during F2Q and has - 32 million shares remaining under current buyback authorizations; 6) MDT provided detail on its recent acquisitions including Ardian, ATS Medical, and Invatec. 7) MDT noted that the future launch timing of certain devices within in Cardiac and Vascular group will be impacted by the timing of the final resolution to the company's Mounds View warning letter."
Barclays maintains an 'Overweight' on Medtronic, Inc., which closed Thursday at $35.21, up $0.50, or 1.44 percent. They have a price target of $38 on them.
Subscribe to:
Posts (Atom)